Unprofitable biotech Veradermics, which still needs FDA approval for its hair loss pill, surged on its debut day.

Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...

The Traits Company, an agricultural biotechnology company headquartered in Research Triangle Park, has announced a strategic collaboration with U.K.-based Wild Bioscience to accelerate the development ...

J&K Ingredients has entered a partnership with Pallas Biotech Co. Ltd., a global biotechnology company, that brings together complementary capabilities across research and development, fermentation, ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

DermCeutical EDLTM is a topical bioactive ingredient that Debut claims delivers skin-tightening benefits.

Feb 4 (Reuters) - Biotech firm PrimeGen US will go public in the United States through a $1.5 billion deal with blank-check ...

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility.

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...